Abstract
Male Sprague-Dawley rats were fed for 30 days a high-fat liquid ethanol diet with dihydroxyacetone, pyruvate and riboflavin added as supplements (AMA-). Plasma triglyceride (TG) levels were 6-fold greater in these rats than in those fed and alcohol with without the supplements (AA-). The liver TG content in rats fed the AMA-diet was similar to that of rats fed a control diet (CA-) in which alcohol was replaced with isocaloric amounts of dextrose. Livers of rats fed the AA- diet had 3 times more TG than controls. Alcohol ingestion also enhanced the hepatic content of cholesteryl esters (CE) and phospholipids (PL). These lipids were reduced to levels found in livers of rats fed the control diet (CA-) when dihydroxyacetone, pyruvate and riboflavin were included in the alcohol diet. The fatty acid compositions of TG, CE and PL from livers of rats fed the AMA-diet were similar to those of corresponding lipids from rats fed the control diet (CA-) but differed from compositions when fed the alcohol diet (AA-). Regardless of the diet fed, TG had the same fatty acid composition in plasma and liver. The same was true of PL fatty acid composition. However, the fatty acid composition of CE differed between liver and plasma. The major fatty acid in liver CE was 18∶1 whereas in plasma it was arachidonic acid (20∶4). Reduced fatty liver was observed in an earlier study when rats were fed ad libitum an ethanol diet containing 20∶4. In the present study, we pair-fed the same diet and fatty liver was not reduced. Dihydroxyacetone, pyruvate and riboflavin did not prevent alcohol-induced fatty liver when 20∶4 was included in the AMA-diet. Our results confirm that dietary dihydroxyacetone, pyruvate and riboflavin prevent alcohol-induced fatty liver, and show that this effect may result from increased mobilization of fat from liver.
Similar content being viewed by others
References
Lieber, C.S., D.F. Jones and L.M. Decarli, J. Clin. Invest. 44:1009 (1965).
DeCarli, L.M., and C.S. Lieber, J. Clin. Nutr. 91:331 (1967).
Lieber, C.S., Gastroenterology 65:821 (1973).
Goheen, S.C., E.C. Larkin, M. Manix and G.A. Rao, Lipids 15:328 (1980).
Stanko, R.T., H. Mendelow, H. Shinozuka and S.A. Adibi, J. Lab. Clin. Med. 91:228 (1978).
Rao, G.A., K. Siler and E.C. Larkin, Lipids 14:30 (1979).
Folch, J., M. Lees and G.H. Sloane-Stanley, J. Biol. Chem. 226:497 (1957).
DeCarli, L.M., and C.S. Lieber, J. Nutr. 91:331 (1967).
Lieber, C.S., N. Spritz, N. and L.M. DeCarli, J. Clin. Invest. 45:51 (1966).
Dajani, R.M., and C. Kouyoumjian, J. Nutr. 91:535 (1967).
Hernandez-Munoz, R., A. Santamaria, J.A. Garcia-Sainz, E. Pina and V. Chagoya de Sanchez, Arch. Biochem. Biophys. 190:155 (1978).
Nikkila, E.A., and K. Ojala, in “Alcohol and the Liver,” Vol. 232, edited by M.M. Fisher and J.G. Rankin, Plenum, New York, NY, 1977, p. 814.
Lieber, C.S., and N. Spritz, J. Clin. Invest. 45: 1400 (1966).
Johnson, O., O. Hernell and T. Olivecrona, Lipids 10:765 (1975).
Jeffcoat, R., in “Essays in Biochem,” Vol. 15, edited by P.M. Campbell and R.D. Marshall, Academic Press, New York, NY, 1979, p. 1.
Baraona, E., and C.S. Lieber, J. Clin. Invest. 49:769 (1970).
Wang, L., and R.C. Reitz, Fed. Proc. 39:541 (1980).
Nervi, A.M., R.O. Peluffo, R.R. Brenner and A.I. Leikin, Lipids 15:263 (1980).
Alpers, D.H., and K.J. Isselbacher, in “Diseases of the Liver,” edited by L. Schiff, J.B. Lippencott Co., Philadelphia, PA, 1975, p. 815.
Author information
Authors and Affiliations
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/BF02534973.
About this article
Cite this article
Goheen, S.C., Pearson, E.E., Larkin, E.C. et al. The prevention of alcoholic fatty liver using dietary supplements: Dihydroxyacetone, pyruvate and riboflavin compared to arachidonic acid in pair-fed rats. Lipids 16, 43–51 (1981). https://doi.org/10.1007/BF02534920
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02534920